Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbal Ecstacy "safe," "no side effect" claims will be halted under FTC settlement.

This article was originally published in The Tan Sheet

Executive Summary

HERBAL ECSTACY "SAFE", "NO SIDE EFFECTS" CLAIMS WILL BE HALTED under a settlement agreement between the Federal Trade Commission and Venice, Calif.-based Global World Media Corp. and its owner, Sean Shayan, announced July 29. All future advertising and promotions for the ephedra (ma huang)-containing dietary supplement must be truthful and warn consumers of the potentially serious side effects associated with ephedra, the settlement states. Global Media and Shayan also have agreed to "refrain from promoting Ecstacy or any similar product for its mind-altering effects in media with a predominant youth audience" (50% or more under age 21).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087369

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel